the Effect of Core Stability on Hand Functions

October 23, 2023 updated by: Gülçe İrem Yalçınkaya

Investigation Of The Effect Of Core Stability On Hand Functions In Patients Undergoing Rotator Cuff Surgery

Determining the factors affecting hand function after upper limb injuries is very important for maintaining independence in daily living activities. The aim of this study is to determine the relationship between core stability and hand function in patients undergoing rotator cuff surgery and to compare the results with healthy patients of a similar age. The aim of this study is to determine the relationship between core stability and hand function in patients undergoing artroscopic cuff surgery.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The shoulder joint is a joint that is open to injuries due to its wide December of movement. For this reason, it is the most important cause of upper extremity pain.The most common cause of shoulder pain is rotator cuff injuries.Rotator cuff injuries are a painful problem of the shoulder that causes movement restriction, pain and impaired functional activities. Excessive use of the shoulder occurs as a result of impaired shoulder stability, November, muscle weakness, trauma. Although the prevalence of rotator cuff ruptures increases with age, they usually start at the age of 40 and the incidence increases by 54% at the age of 60 and by 60- 80% at the age of 80. It has a prevalence ranging from 20-50% in the general population. Arthroscopic repair has found widespread use due to the reasons that the protection of the adhesion site of the deltoid November, the diagnosis and treatment of concomitant intra-articular pathologies are easier, adhesions are less common, pain is less and rehabilitation after repair is easier.Core stability is considered very important in terms of biomechanical efficiency because it optimizes force production in all kinds of physical activities, from running to throwing, and minimizes the loads placed on the joints. However, there is little clarity about exactly what the anatomical and physiological characteristics of the structures that make up core stability are. However, core stability is defined as the ability to control the position and movement of the trunk on the pelvis to allow optimal production, transfer and control of force and movement to the terminal segment during activities. Core November muscle activity is best understood as the pre-programmed integration of regional, single-jointed and multi-jointed muscles to provide stability and November muscle activity is best understood as the pre-programmed integration of regional, single-jointed and multi-jointed muscles to produce movement. This results in the creation of proximal stability for distal mobility, a proximal-to-distal model of force generation, and interactive moments that move and protect the distal joints . Strong core stabilization minimizes the load on the vertebral column, increases the durability of the peripheral joints and also provides energy transfer to the distal segments. The relationship between core stability and limb Deceleration performance has been studied in athletes in general. However, most of the studies have focused on core stability and lower limb relationship.Evaluation of hand function and performance is important in terms of determining the person's skill level in daily life activities and demonstrating the effectiveness of rehabilitation.Hand function can be defined as the capacity of the hand for daily activities in connection with anatomical integrity, mobility, strength, sensation, coordination, age, gender, mental status, illness or trauma, and the condition of other proximal limb joints (shoulder, elbow, wrist). In order to determine which approaches are more effective in correcting the loss of function that occurs after various injuries and diseases, it is first necessary to have a good understanding of the factors that affect this performance.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
94

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Denizli, Turkey
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Study group: 47 patients between the ages of 40-75 Control group : 47 healthy adults between the ages of 40-75

Description

Inclusion Criteria:

  • - Patients who have had rotator cuff repair done (at least one year ago)
  • Non-rerupturants
  • Those who have not suffered any other upper limb injuries after surgery
  • Those who do not have any chronic diseases that can negatively affect ligament healing
  • Those who do not have any spinal and lumbar region pathology
  • Those who do not have lower back and back pain
  • Those who do not have any neuromuscular diseases
  • Those who can be cooperated

Exclusion Criteria For Volunteers:

  • Patients who have not had rotator cuff repair
  • Those who are recurrent
  • Those who have suffered any other upper limb injury after surgery
  • Those with any chronic diseases that can negatively affect ligament healing
  • Those with any spinal and lumbar region pathology
  • Those with lower back and back pain
  • Those who have undergone spinal surgery
  • Those with any neuromuscular disease
  • Those who cannot establish coperation

Exclusion Criteria:

  • Patients who did not complete the evaluations and wanted to leave voluntarily were excluded from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Study group
Patients between the ages of 40-75 who had rotator cuff repair at least one year ago at the Orthopedics and Traumatology Clinic of Pamukkale University
Other: clinical evaluation
clinical evaluation tests
Control group
healthy adults between the ages of 40-75
Other: clinical evaluation
clinical evaluation tests

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
hand dominance test
Time Frame: 1 year
Edinburgh Hand Preference Survey
1 year
muscle strength test
Time Frame: 1 year
Jamar Hand Dynamometer
1 year
Evaluation of reaction time test
Time Frame: 1 year
Nelson hand reaction test
1 year
upper extremity function test
Time Frame: 1 year
Q-DASH Survey
1 year
hand function test
Time Frame: 1 year
Jebsen Taylor Hand Function Test
1 year
upper extremity balance test
Time Frame: 1 year
Upper Extremity Y Balance Test
1 year
core stabilization test
Time Frame: 1 year
Core Stabilization Assessment (trunk flexor, trunk extensor endurance, side plank, double straight leg lowering)
1 year
Pain scale
Time Frame: 1 year
Visual Analog Scale (VAS)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Gülçe İrem Yalçınkaya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 25, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 23, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 25, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 7, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 23, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 27, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 27, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 23, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Pamukkale Universty

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings